Related stories
Samsung Biologics’ KRW2.7T Rights Offering Oversubscribed
Samsung Biologics received bids for 11.9 million new shares against 2.3 million offered. The company previously said the sale would help fund its PolyPeptide acquisition.
M impact | EQUITY | Nov 16, 2026, 06:32 AM UTC
Net Protections to Buy Back Up to 3.5% of Shares for ¥1.2 Billion
L impact | EQUITY | Nov 16, 2026, 06:32 AM UTC
Asian session market picture: S&P 500 -0.56%, Nasdaq 100 -1.22%; USD/JPY -0.14%, WTI +0.68%, 1810 leads volume
Asian session market picture. US index futures: S and P futures is down 0.56 percent, Nasdaq futures is down 1.22 percent, Dow futures is down 0.2 percent and Russell futures is do
M impact | EQUITY | Nov 16, 2026, 06:31 AM UTC
Nikkei Stock Average Closes 2.4% Lower at 59,662.02
The index fell 2.4%, dragged by chip stocks.
M impact | EQUITY | Nov 16, 2026, 06:30 AM UTC
Mahindra Logistics shares fall up to 15% after Hemant Sikka quits as MD & CEO
Shares of Mahindra Logistics plunged as much as 14.5% on Monday, November 16, marking the biggest-ever intraday fall in the stock's history. The sharp decline came after the compan
L impact | EQUITY | Nov 16, 2026, 06:22 AM UTC
Morgan Stanley Sees S&P 500 at 8,700 by Year-End 2027
M impact | EQUITY | Nov 16, 2026, 06:14 AM UTC